Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Silo Pharma Inc
(NQ:
SILO
)
3.500
+1.250 (+55.56%)
Streaming Delayed Price
Updated: 3:40 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
103,633,907
Open
2.360
Bid (Size)
3.500 (1)
Ask (Size)
3.530 (27)
Prev. Close
2.250
Today's Range
2.360 - 4.500
52wk Range
0.8410 - 3.050
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
Today 14:31 EDT
Via
Benzinga
Topics
Earnings
Exposures
Financial
Why Is Silo Pharma (SILO) Stock Up 60% Today?
Today 14:25 EDT
With developmental-stage Silo Pharma inking a partnership to forward PTSD drugs, SILO stock shot higher on the credibility boost.
Via
InvestorPlace
Performance
YTD
+130.27%
+130.27%
1 Month
+233.41%
+233.41%
3 Month
+78.58%
+78.58%
6 Month
+150.01%
+150.01%
1 Year
+71.57%
+71.57%
More News
Read More
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Today 13:19 EDT
Via
Benzinga
Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug
Today 12:44 EDT
Via
Benzinga
Why Is Silo Pharma (SILO) Stock Up 123% Today?
July 16, 2024
Via
InvestorPlace
Dow Dips 250 Points; US Weekly Jobless Claims Surge
Today 12:06 EDT
Via
Benzinga
Topics
Stocks
Exposures
US Equities
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Enters Device and CMC Development Master Plan to Support IND-Enabling Study of SPC-15
Today 10:46 EDT
Via
Investor Brand Network
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
Today 10:04 EDT
Via
Benzinga
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
Today 8:25 EDT
From
Silo Pharma, Inc.
Via
GlobeNewswire
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
July 17, 2024
Via
Benzinga
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
July 16, 2024
Via
Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via
Benzinga
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
July 16, 2024
Via
Benzinga
Exposures
Fossil Fuels
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Exclusive Global License to Develop, Manufacture, Commercialize Alzheimer Drug
July 16, 2024
Via
Investor Brand Network
Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
July 16, 2024
Via
Benzinga
Exposures
Product Safety
Dow Jumps 400 Points; US Retail Sales Flat For June
July 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?
July 16, 2024
Via
InvestorPlace
Why Is Autonomix Medical (AMIX) Stock Down 17% Today?
July 16, 2024
Via
InvestorPlace
Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?
July 16, 2024
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 16, 2024
Via
InvestorPlace
Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic
July 16, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters License Agreement with Columbia University for Lead Candidate Targeting PTSD, Stress-Induced Anxiety Disorders
July 08, 2024
Via
Investor Brand Network
Exposures
Product Safety
Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
July 08, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSD
June 26, 2024
Via
Investor Brand Network
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
June 26, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.